Researchers at the Mayo Clinic are utilizing autologous (the patient’s own) mesenchymal stem cells to treat spinal cord injuries. Traumatic spinal cord injuries cause permanent damage to functional and motor skills of patients, and often leads to paraplegia or tetraplegia - a complete paralysis of the body either from the neck or the waist down. These injuries most often arise from car accidents and severe falls, affecting hundreds of thousands of patients each year. Typically, there is no ability for rehabilitation for tetraplegic and paraplegic patients. Hence, an autologous stem cell therapy that restores function would represent a groundbreaking advance.
Doctors at the Mayo Clinic targeted a patient suffering severe debilitation from their spinal cord injury. Following the recovery of their stem cells [in this case – from adipose], the cells were concentrated, expanded and then cryopreserved awaiting treatment. The stem cells were then reintroduced into the patient, who experienced no adverse effects and showed clinical signs of motor and sensory improvements when observed in long-term follow-ups. These significant and promising results demonstrate the potential of autologous stem cells to effectively treat currently incurable trauma and improve a patient’s quality of life. The positive results of the study point to expanded clinical trials in the near future.
Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.